Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

BAVARIAN NORDIC

BAVA.CODK0015998017NASDAQ CopenhagenDKDKK
Stock price
BAVARIAN NORDIC
Loading chart...

Coverage

Latest articles

Nations stockpile mpox vaccine amid rising geopolitical fears
9 Jul 2025, 14:48BAVA.CONASDAQ Copenhagen

Filings

Recent filings

FilingDate
Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government16 Dec 2020
Bavarian Nordic Introduces New Employee Incentive Program 8 Dec 2020
Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.16 Nov 2020
Correction: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such13 Nov 2020
Bavarian Nordic Announces Interim Results for the First Nine Months of 2020 11 Nov 2020
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such11 Nov 2020
Bavarian Nordic Announces Appointment of Anu Helena Kerns as Executive Vice President, People and Organization
Search

Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.

Bavarian Nordic sells vaccine voucher for $160 million
20 Jun 2025, 17:26BAVA.CONASDAQ Copenhagen

Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.

  • Previous
  • 1
  • 2
  • 3
  • Next
9 Oct 2020
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program2 Sept 2020
Bavarian Nordic Announces First Half 2020 Results26 Aug 2020
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations26 Aug 2020
Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine24 Aug 2020
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine22 Jul 2020
  • Previous
  • 1
  • More pages
  • 19
  • 20
  • 21
  • More pages
  • 78
  • Next
Company
BAVARIAN NORDIC
BAVA.CONASDAQ Copenhagen
Website: Unavailable
Coverage
14
Filings
927